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Abstract
The Liverpool epidemic strain (LES) is an important transmissible clonal lineage of Pseudomonas aeruginosa that chronically 
infects the lungs of people with cystic fibrosis (CF). Previous studies have focused on the genomics of the LES in a limited 
number of isolates, mostly from one CF centre in the UK, and from studies highlighting identification of the LES in Canada. 
Here we significantly extend the current LES genome database by genome sequencing 91 isolates from multiple CF centres 
across the UK, and we describe the comparative genomics of this large collection of LES isolates from the UK and Canada. 
Phylogenetic analysis revealed that the 145 LES genomes analysed formed a distinct clonal lineage when compared with the 
wider P. aeruginosa population. Notably, the isolates formed two clades: one associated with isolates from Canada, and the other 
associated with UK isolates. Further analysis of the UK LES isolates revealed clustering by clinic geography. Where isolates 
clustered closely together, the association was often supported by clinical data linking isolates or patients. When compared 
with the earliest known isolate, LESB58 (from 1988), many UK LES isolates shared common loss- of- function mutations, such as 
in genes gltR and fleR. Other loss- of- function mutations identified in previous studies as common adaptations during CF chronic 
lung infections were also identified in multiple LES isolates. Analysis of the LES accessory genome (including genomic islands 
and prophages) revealed variations in the carriage of large genomic regions, with some evidence for shared genomic island/
prophage complement according to clinic location. Our study reveals divergence and adaptation during the spread of the LES, 
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DATA SUMMARY
The GenBank accession numbers of the genomes used in this 
study that have previously been deposited in the National 
Center for Biotechnology Information (NCBI) database, 
along with the published studies they were analysed for, have 
been provided in Table S1 (available in the online version of 
this article). Genomes sequenced for this study have been 
deposited in the NCBI Genome database under the BioProject 
ID PRJNA615626 and their accession numbers are provided 
in Table S1.
INTRODUCTION
Chronic lung infections with the versatile pathogen Pseu-
domonas aeruginosa remain the major cause of morbidity 
and mortality associated with cystic fibrosis (CF). During 
the infection process in the CF lung, the bacterium under-
goes characteristic adaptive changes [1], making it diffi-
cult or impossible to eradicate once established. Because 
P. aeruginosa can prosper in a wide variety of environmental 
and clinical niches, exposure to it is inevitable, and it is still 
a wide assumption that the majority of CF patients acquire 
their infections from an environmental source. However, it 
has become clear that specialist clones of P. aeruginosa capable 
of patient- to- patient transmission exist [2, 3], leading to over- 
representation amongst isolates from CF. The occurrence of 
such strains presents additional challenges in terms of patient 
care, but their identification does enable steps to be taken to 
minimize transmission amongst patients [4]. One of the best- 
studied transmissible clones is the Liverpool epidemic strain 
(LES), first discovered in a children’s CF unit in Liverpool 
[5], but since identified as the most common single clone 
amongst CF isolates from patients in the UK [6]. The LES 
lineage has also been identified in Canada [7, 8]. The LES has 
a number of important characteristics, including the ability 
to superinfect [9], increased production of some virulence 
factors [10, 11], an association with increased morbidity [12], 
increased resistance to antimicrobials [13] and the ability to 
cause infections beyond the CF host, including infections of 
the non- CF parents of a CF patient [14] and a patient’s pet 
cat [15]. The strain has also been reported as causing pleural 
empyema in a CF patient [16] and has been isolated from 
patients with primary ciliary dyskinesia and non- CF bron-
chiectasis (unpublished data).
Since the first P. aeruginosa genome was published in 2000 
[17], a number of other complete P. aeruginosa genomes have 
been made available [18–24]. Whole- genome sequence data 
have also been used for analyses of within- clone variation for 
the two most abundant P. aeruginosa clones globally (PA14 
and clone C) [25]. The complete genome of the earliest known 
LES isolate (LESB58 from 1988) was published in 2009 [26], 
revealing a number of genomic features, including five GIs 
GIs) and six prophages, some of which have been implicated 
in the competitiveness of the strain in vivo [26, 27], and five 
of which can be detected as free phages in CF patient sputa 
[28]. Since then, 3 further genomes from LES isolates from 
Liverpool [29] and 12 from Ontario, Canada [8] have been 
reported. In addition, further LES isolate genomes have been 
sequenced from the adult CF unit in Liverpool in studies, 
suggesting the co- existence within patients of distinct LES 
sub- lineages [30–32].
The aim of this study was to determine the genome sequences 
of a larger collection of LES isolates from multiple centres 
throughout the UK and analyse the resulting extended dataset 
in order to characterize the diversity of a major CF trans-
missible strain in the context of geographical and temporal 
dissemination. Our data support the sub- division of LES 
isolates into distinct UK and Canadian clades, with some 
additional clustering by centre within the UK, and reveal 




Details of all the LES isolates included in the genomic analysis 
are given in Table S1. In total, 145 LES genomes were analysed, 
including the genomes of 91 isolates sequenced for this study. 
The majority of the newly sequenced isolates were obtained 
from the collection at Public Health England (PHE), Colindale 
or the archived collection in Liverpool. Additional UK genomes 
were obtained from CF centres in the West Midlands and East 
Midlands. Amongst the published genomes included were 
representatives of different sub- lineages of the LES identified 
in a study of isolates in the Liverpool Adult CF Unit [30].
Genome sequencing of bacterial isolates
DNA was extracted from 91 LES isolates using the Promega 
Wizard genomic DNA extraction kit. Whole genomes 
Impact Statement
Chronic lung infections caused by Pseudomonas aerugi-
nosa are the major cause of the morbidity and mortality 
associated with cystic fibrosis. In the UK and Canada, a 
particular lineage of P. aeruginosa (the Liverpool epidemic 
strain, or LES) possesses unusual characteristics: it can 
transmit between patients and is associated with greater 
morbidity. In the UK, the LES lineage is the most common 
lineage found amongst CF isolates. Using whole- genome 
sequencing and comparative genomics analyses, we 
have analysed 145 LES isolates from across the UK and 
Canada, providing the most comprehensive analysis to 
date of the LES lineage. We demonstrate geographical 
clustering of LES isolates, and describe how the lineage 
has adapted and diverged. In particular, we show diver-
gence between isolates in Canada compared to the UK, 
and variations between isolates from different UK clinics. 
Our analysis has identified adaptations that might 
contribute to the success of this lineage as a pathogen 
in cystic fibrosis.
3
Moore et al., Microbial Genomics 2021
were sequenced either by the Centre of Genomic Research 
(CGR), Liverpool, using Nextera library preparation and 
an Illumina HiSeq sequencer or at Institut de Biologie 
Intégrative et des Systèmes (IBIS), Université Laval, Canada 
on the Illumina MiSeq platform. An additional 54 previ-
ously published LES genomes were included in the analysis 
[8, 29, 30]. These included a resequenced strain LESB58, 
labelled as genome LESB58_2. Three hundred and ninety 
non- LES P. aeruginosa genomes were obtained from a 
published P. aeruginosa genomics study [23] to represent a 
wider P. aeruginosa population set.
Genome assemblies
Short reads were adapter- trimmed and quality- filtered 
using cutadapt-1.9.2 [33] and assembled to the contig level 
using the A5 assembly pipeline [34]. The de novo- assembled 
contigs were scaffolded to the genome of LESB58 [26] 
using ABACAS [35]. Contigs containing sequence acces-
sory to the LESB58 genome were appended to the end 
of each draft genome. All genomes were annotated with 
Prokka-1.12, including CRISPR prediction [36]. The  pseu-
domonas. com database [37] was used to facilitate further 
assessment of gene function and the impact of mutations. 
Multilocus sequence types (MLSTs) were determined using 
mlst (https:// github. com/ tseemann/ mlst) and the pubmlst 
database [38].
Core genome phylogeny
In order to assess the placement of the LES lineage in the 
wider P. aeruginosa population, a relaxed core P. aeruginosa 
tree was inferred from the LES genomes and the 390 P. aerugi-
nosa genomes from a previous genomics study [23]. LESB58 
was designated as the initial reference genome for Panseq 
[39], followed by random successive reference selection for 
genomic regions not present in previous reference genomes. 
Successive reference genomes were split into 500 bp fragments 
and pairwise aligned to all other genomes. Fragments with at 
least 90 % blast percentage identity to the reference in 95 % 
of taxa (508/535) were designated as belonging to the relaxed 
core, aligned with clustalw [40] and concatenated with 
SCaFoS [41]. The resulting 5 517 752 bp supermatrix contained 
429 463 informative sites. The tree was inferred by maximum 
likelihood (ML) with the HKY85 substitution model and 1000 
ultrafast bootstrap (UFBoot) [42] replicates for branch support 
using IQ- TREE-1.6.2 [43]. To assess the root position of the 
LES lineage, this was repeated with the 145 LES genomes and 
P. aeruginosa reference genomes and known outgroups: PAO1 
and PA14 [17, 44]. Fragments were defined as core if they had 
90 % blast percentage identity with the reference and were 
present in 95 % of taxa (141/147). This resulted in a 5 840 172 
bp relaxed core supermatrix including 14 730 informative 
sites. The TIM+R5 substitution model was determined as the 
best fit for the data by IQ- TREE [43] model test [45] and the 
phylogenetic tree was inferred by ML with 1000 UFBoot repli-
cates, where at least 95 % confidence is recommended as well 
supported. The tree was rooted between outgroups PAO1 and 
PA14 and the rest of the tree. Finally, snippy (https:// github. 
com/ tseemann/ snippy) was used with default parameters to 
generate a substitutions- only LES core single- nucleotide poly-
morphism (SNP) alignment from all LES assemblies and the 
tree was approximated using runListCompare (https:// github. 
com/ davideyre/ runListCompare), which uses IQ- TREE [43] for 
model selection and phylogeny inference, and ClonalFrameML 
[46] for the identification of recombinant sites to be removed 
from the alignment. LESB58 GI and prophage regions [26] were 
also masked. The GTR+F+G4 substitution model was selected 
by IQ- TREE and there were 2947 informative sites. Phylogenetic 
trees were visualized with either the interactive tree of life soft-
ware (iTol) [47] or GrapeTree [48]. SNP distances were plotted 
using the Python packages seaborn (https:// seaborn. pydata. 
org/), matplotlib [49], pandas [50] and numpy [51] with the 
Jupyter Notebook environment [52].
Core and accessory genes
The core and accessory gene content of the LES genomes 
was determined by Roary [53] using Prokka- annotated gff 
files as input and without splitting paralogues. This was 
repeated for the LES plus the wider P. aeruginosa population 
genomes, but with paralogue splitting. Genes determined 
to be ‘strict core’ in the pangenome analysis by Roary were 
present in >=99 % of the total set and relaxed core >=95 %. 
Association tests of accessory gene content and Benjamimi–
Hochberg (BH) multiple testing corrections were performed 
by SCOARY [54] using the Roary- generated gene presence/
absence matrix output as input. Abricate (https:// github. 
com/ tseeman/ abricate) was used to investigate the potential 
presence of antibiotic resistance- conferring genes.
Structural analysis
The assembled genomes were also compared to LESB58 for 
large, structural differences using the blast Ring Image 
Generator (BRIG) [55] to identify large (10 kb or greater) 
deletions. The presence and absence of virulence genes in 
the assembled genomes was investigated using Blastable 
v0.4, a Python script (https:// github. com/ bawee/ blastable) 
that performs a nucleotide blast+ search. To further inves-
tigate the presence and absence of LESB58 prophages and 
GIs, a database of LES genomes was generated using blast+ 
[56] makeblastdb, against which each LESB58 prophage and 
GI was aligned using blast+ blastn (window size 28). 
Percentage identity was corrected for the contribution of 
duplicate regions present elsewhere in the draft genome by 
reciprocally aligning known duplicate regions with blastn 
[28].
Identification of SNPs and microindels in UK LES 
relative to the genome of LESB58
High- quality SNPs and microindels in the UK LES 
genomes for which short reads were available were called 
against the completed LESB58 reference genome, which 
is the outgroup to the UK LES and the oldest dated LES 
isolate [26, 30]. Quality- filtered short reads were mapped 
to reference genome LESB58 with bwa0.7.5a mem [57]. 
The LESB58 genome (.fasta) was indexed with bwa-0.7.5a 
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index [57] and samtools-0.1.18- r580 [58] faidx. A sequence 
dictionary was created with picard- tools-1.135 [59] –Crea-
teSequenceDictionary. The resulting sequence alignment 
map (.sam) file from read mapping with bwa was converted 
to a binary alignment map (.bam) file using picard- tools 
SortSam. Duplicates were marked using picard- tools 
MarkDuplicates and a bam file index created with picard- 
tools BuildBamIndex. The Genome Analysis Toolkit-3.4 
(GATK) [60] Realignor Target Creator was used to desig-
nate targets for indel realignment and indels were realigned 
with GATK IndelRealigner. Variants were called using 
GATK HaplotypeCaller (- ploidy 1- emitRefConfidence 
GVCF) to produce a variant call (.vcf) file prepared for 
genotyping. The vcf file was genotyped using GATK Geno-
typeGVCFs and filtered using vcffilter [61] basic filtering 
(DP >9 and QUAL >10). Variant annotation was performed 
by snpEff-4.1l [62] with the default parameters for GATK 
output (- eff -gatk) to the LESB58 reference genome anno-
tation database, uid59275. Additionally, we determined 
whether genes had larger deletions not detectable due to 
lack of sequencing reads and absence of genomic context in 
vcf files. First bam files were indexed with samtools index 
and the reads aligned to a regions determined by snpEff 
database gene regions using samtools depth. Genes with 
any deletions larger than 20 bp were not considered for 




A geographically and historically diverse sample of LES 
isolates was selected for this study (n=91) and was combined 
with a set of previously sequenced LES genomes (n=54). 
The newly sequenced genomes were primarily isolated from 
CF patients, but also included some isolates from primary 
ciliary dyskinesia (PCD) patients, a pet cat (OSIRIS) [63], 
non- CF bronchiectasis (nCFBr) patients, a blood isolate 
(PHELES19) and the non- CF parents of a CF patient 
[14]. All LES genomes analysed in this study, and their 
geographical source (according to PHE regions) and date 
of isolation, if known, are presented in Table S1. The mean 
number of CDS per genome was 6004, with a range of 5854 
(PHELES12) to 6506 (JD324). Nearly all LES genomes, with 
the exception of those from isolates prefixed with ‘JD’, and 
‘MdLES’, were predicted to carry type 1 CRISPR sequences.
The LES genomes form a distinct lineage amongst 
the wider P. aeruginosa population
A relaxed core genome was extracted from a combination of all 
the LES genomes plus the wider P. aeruginosa population set. 
The LES was resolved as a monophyletic, clonal lineage (Fig. 1). 
The lineage is composed of two MLST sequence types, ST-146 
(primarily) and ST-683, that differ in the ppsA locus. Of the 
145 LES genomes, 128 were ST-146, 2 were ST-683 and 15 did 
Fig. 1. Phylogenetic inference of LES genomes and 390 genomes from a previous study representative of the wider Pseudomonas 
aeruginosa population. The tree was constructed with IQ- TREE [43] maximum likelihood, the HKY85 substitution model and 1000 ultra- 
fast bootstrap support replicates from a relaxed core fragment supermatrix (500 bp fragments present in >=95% of genomes) with 
429463 informative sites. The tree was visualized by GrapeTree [48] with branches log- transformed and nodes collapsed and coloured 
by MLST. MLSTs are included in the key for those represented by two or more genomes
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not correspond to known STs, differing from ST-146 by 1 locus 
in each case. The wider tree largely resolved into two major 
P. aeruginosa phylogenetic groups, but with a few lineages being 
placed in neither of the major groups, consistent with previous 
analysis [64]. One genome from the wider population set was 
placed within the LES clade, namely isolate AZPAE13757_2337, 
associated with a respiratory tract infection (RTI) from Canada. 
This isolate also carries the LES serotype (06) and MLST 
(ST-146) and was therefore coded as LES in the gene association 
analysis [23].
A tree of the LES genomes included in this study, with 
additional genomes from the reference strains PAO1 and 
PA14, was reconstructed based on a relaxed core genome 
fragments supermatrix. The LES genomes clustered into 
two major phylogenetic groups, with clade I containing 
mainly Canadian isolates and clade II containing entirely 
UK- sourced isolates. The root position was determined 
with 100% UFBoot support to be within clade I (Fig. S1).
Phylogenetic analysis reveals clustering by clinic 
geography
The LES reference genomes representing the oldest known LES 
isolate, LESB58 (whole genome) and LESB58_2 (resequenced 
with Illumina data, 2.93 SNPs different) were placed between 
the two clades, and thus represented an outgroup to the rest of 
the UK genomes (Fig. 2). There were two main exceptions to 
the general rule of separation according to country of origin. 
Clade I contained two LES isolate genomes sampled from 
Fig. 2. Phylogenetic tree inferred from core SNPs with LESB58 GIs and prophages masked. Recombinant sites determined by 
ClonalFrameML were excluded. The GTR+F+G4 substitution model was selected by IQ- TREE and there were 2947 informative sites. 
The tree was visualized by iTol [47] with colour strip and branch colours indicating PHE designated regions of isolation or Canada. For 
visualization branch lengths >70 SNPs were truncated and marked with a star. Plotted around the tree is a heatmap of percentage 
identity with LESB58 prophage and GI regions, prophages 2–6 and GIs 1–5.
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the UK: LiP6 and PHELES19. Further investigation revealed 
that the patient infected with LiP6 had lived in Canada, but 
no further information was available for the patient infected 
with PHELES19, other than the fact that this was a blood 
isolate. Within clade II there was phylogenetic evidence for 
further clustering by source of isolation within the UK and 
between patients known to be in contact with one another. 
Where genomes from one region or clinic were placed within 
a UK sub- clade dominated by genomes from a different 
clinic or region, further information was sought about 
possible previous patient links to the region. PHELES10 and 
PHELES16 were isolated from patients in the East of England 
in 2014, but fall within a majority East Midlands clade. Both 
patients were recorded as attending and presenting samples 
prior to 2014 in the East Midlands CF unit. PHELES1 was 
isolated from a patient in Scotland, but falls within a majority 
East Midlands clade; this patient had previously attended the 
East Midlands CF clinic. Although many sub- clades of the 
LES had a clear geographical association (Fig. 2), there were 
some examples of isolates from different origins clustering. 
For example, isolates PHELES20, 4, 15, 12 and 23 cluster 
together despite being from different geographical locations. 
However, we do not have sufficient information about patient 
histories to explain this.
The LES tree was corrected for recombination after likely 
recombinant regions were detected in 30 inner nodes of 
the tree and 109 tip- branches (Fig. 2). Within clade I the 
median recombination corrected pairwise branch length 
(193.92 SNPs) was longer than within clade II (119.72 SNPs), 
including LESB58 (Figs S2 and S3a). The longer clade I branch 
lengths could either be due to the lineages being older, sparse 
sampling or that the clade II genomes by comparison have 
transmitted faster. Overall, the median branch lengths within 
the LES tips were 131.11 SNPs (of 10 440 exclusive pairs).
Phylogenetic analysis reveals clustering supported 
by clinical history
Individual CF patients (identified as isolates that are desig-
nated with names commencing with ‘CF’ followed by a 
common number, for example CF5S120, CF5S138 and 
CF5S134, all from patient CF5) typically clustered together. 
In a previous study by Williams et al. [30] with extensive 
within- patient sampling within a single CF clinic it was 
possible to determine that there were coexisting distinct line-
ages of the LES within individual patients. The coexistence of 
divergent lineages within patient CF3 were further confirmed 
here with two separate clusters (one containing CF3S124, 
CF3S235, CF3S224 and CF3S108; the other containing 
CF3S25, CF3S219 and CF3S225). The branch length between 
randomly selected genomes from each cluster, CF3S235 and 
CF3S219 was 108 SNPs.
The shortest branch lengths were most often between within- 
patient samples, though some branch lengths for isolates from 
different patients were shorter than between within- patient 
isolates, suggesting recent transmission or conversely distinct 
coexisting lineages within patients (Table S2). The shortest 
branch lengths from within- patient samples were SED11/
SED20 SED1/SED11, SED1/SED20 [32, 65], with 0, 3.9 and 
3.9 SNPs respectively and CF9S124/CF9S111, with 0.97 SNPs. 
Conversely, between- patient isolate genomes also had smaller 
branch lengths than some within- patient lineage branch 
lengths. These included 49492/30567S with 21.41 SNPs, 72G/
B35 with 18.48 SNPs and PHELES27/PHELES29 with 10.69 
SNPs.
There were a number of examples where isolates clustering 
together were linked based on clinical data. For example, 
isolates 139124 and 139125 (103.2 SNPs) from a single PCD 
patient, and isolate 119579 from their sibling (81.78 SNPs 
to 139 125), also a PCD patient, were adjacent on the tree. 
Isolates PHELES27 and PHELES29 (10.7 SNPs), and isolates 
89204 and 89212 (82.7 SNPs), were isolated from siblings. 
Isolate CFS120 was from a CF patient and clustered with 
417GLY (71.1 SNPs), isolated from their non- CF parent 
[63]. The isolate OSIRIS, isolated from a pet cat, clustered 
with the human isolate 89568 (28.21 SNPs), isolated from the 
owner. Isolates 79426 and 79427(166.6 SNPs), from the same 
empyema patient, clustered together.
Although many sub- clades of the LES had a clear geographical 
association (Fig. 2), there were some examples of isolates from 
different origins clustering. For example, isolates PHELES20, 
4, 15, 12 and 23 cluster together, despite being from different 
geographical locations. However, we do not have sufficient 
information about patient histories to explain this.
The LES accessory genome
The gene content for all LES genomes in this study (the LES 
pangenome) was compared with the pangenome of the wider 
P. aeruginosa population set. To assess significant associations 
between genes and designated groups of either the LES or 
the wider population set, Fisher’s exact test (<0.05) was used 
and BH correction for multiple testing [54]. A pangenome 
with 535 genomes, including the 145 LES genomes, was 
constructed. There were 3251 strict core genes (present in 
>=99 % genomes) of a pangenome of 33 033 different genes 
(where paralogous groups within the same genome were clas-
sified as the same gene). Compared with the wider population 
set, there were 2922 genes significantly associated with the 
LES by absence and 1397 genes significantly associated with 
the LES by presence. There were 152 genes present in >=95 
% of the LES genomes but <=10 % of the wider population. 
Of these 108 are located within LESB58 GIs or prophages, 
particularly LES GI-3 (48 genes), LES prophage 3 (25 genes), 
LES prophage 4 (17 genes) and LES GI-1 (15 genes) (Table 
S3). There were 22 genes that were present in >=95 % of the 
wider population and <=10 % of the LES (Table S4).
We conducted further analyses to identify large regions that 
were absent from some LES isolate genomes. We interrogated 
the LES genomes using abricate in order to seek evidence 
for horizontal acquisition of antibiotic resistance genes. In 
addition to identifying resistance- related genes common to 
all isolates, there was evidence for additional beta- lactamase 
genes in several isolates. In particular, isolates from three 
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different CF patients (CF3S108, CF4S132 and CF7S115) 
harboured class A beta- lactamase TEM-181 genes sharing 
100 % identity with a gene in Escherichia coli (accession 
number NG_050218.1). This gene was not carried by other 
LES isolates from the same patient sputum samples.
Deletions of more than 10 kb were present in 24 of the 
LES sequenced genomes (Fig. S4, Table S5). Twenty eight 
deletions were identified, with seven of the deletions being 
greater than 100 kb, and the largest being 249 kb. CF9S111 
and CF9S124 contained the same deletion, consistent with 
their high sequence similarity and adjoining positions on 
the phylogenetic tree (Fig. 2); the same is true of JD304 and 
LESlike1. Most strains only contained one deletion, although 
four strains contained two. The deletions were non- randomly 
distributed in the genome, with 15 of the 24 strains having 
deletions in the region between 3.10 and 3.50 Mb (Fig. S4). 
This region of the LESB58 genome contains, amongst others, 
genes encoding an extracellular polysaccharide (Psl), a sidero-
phore (pyoverdine) and a type VI secretion system (Table S6).
There were also variations in the carriage of previously 
reported [26] LES GIs and prophage regions (Fig. 2). LES 
prophage 5 was more commonly absent from the LES isolate 
genomes. Carriage of prophage 2 and GI5 was also highly 
variable, with some evidence for shared GI/prophage comple-
ment according to geographical regions (Fig. 2). For example, 
the absence of GI5 was a feature of isolates from the East 
Midlands region. Likewise, there is a cluster of isolates from 
the Liverpool region that lack LES prophages 2 and 5. All of 
the isolates from Canada lacked LES prophage 5, but there 
were variations with respect to both carriage and divergence 
for other GI and prophage regions (Fig. 2).
Mutations in LES genomes
Genomes of clade II (entirely UK- sourced) isolates for which 
short reads were available for high- quality read mapping and 
variant calling (n=124) were assessed for mutations compared 
with the oldest known LES isolate LESB58 (from 1988), as 
reference and outgroup to the clade II LES. There were 19 679 
variants counted across all UK LES compared with LESB58, 
including 10 036 different mutations in 3742 different genes. 
The majority of variants by mutational impact category were 
amino acid substitutions (54.94 %), followed by synonymous 
nucleotide substitutions (20.24 %), frame- shifting mutations 
(9.96 %), mutations upstream of coding regions (9.56 %) 
and premature stop codons gained (2.60 %). The remainder 
(2.69 %) comprised codon insertions, codon deletions, codon 
changes plus insertions, mutations downstream of coding 
regions, stop codon loss, start codon loss, synonymous stop 
codon substitution and non- synonymous start codon substi-
tutions. The majority of different mutations (7507/10 036) 
were only present in one genome. One hundred and six of 
the different mutations were present in 10 or more genomes, 
including 34 carried in each of 100 or more genomes. Muta-
tions in or upstream of 20 different genes were found in all 
124 UK LES genomes relative to LESB58 (Table S7). Two of 
these were synonymous mutations (in phuR and wbpY), and 
two were located upstream of genes. The remaining 16 were 
amino acid substitutions in genes, including in the nosR gene, 
encoding a regulatory protein. It is possible that in these cases, 
LESB58 is the isolate that has acquired a mutation. However, 
the genome of LESB58 is identical to strain PAO1 in the 
region of the nosR mutation, and the mutation identified is 
not present in any of the Canadian LES, suggesting that it 
is a genuine mutation relative to LESB58 in all the UK LES 
isolates.
The reported 14 bp deletion in gltR, previously believed to 
be fixed in UK LES genomes other than LESB58 [29], was 
present in 100/124 UK LES genomes. Of the 24 UK isolates 
not harbouring this deletion, all but one (CF54NCTC13415) 
were associated with a majority East Midlands cluster (from 
isolate 10333 to isolate SED1 on the tree in Fig. 2). This muta-
tion is not present in any of the Canadian LES. A nonsense 
mutation in fleR, also not found amongst the Canadian 
isolates, was present in 122/124 UK LES genomes (Table S7). 
An additional isolate (8835) carried a 28 bp deletion in fleR 
spanning the same locus of the nonsense mutation. LiP1a was 
the only isolate genome analysed without a nonsense muta-
tion in fleR. However, the closely related LiP1c, isolated from 
the same patient as LiP1a, did harbour the nonsense mutation 
in fleR (Fig. 2, Table S7).
There were more non- synonymous mutations in some 
genes than others, suggesting ongoing adaptation as the 
strain spread around the UK. The majority of different genes 
carrying a nonsense mutation represented a single acquisition 
(615/742), including those present in only one isolate genome. 
The remaining 127 different genes were inferred to have inde-
pendently acquired nonsense mutations in the population 
between 2 and 32 times. Those with four or more independent 
acquisitions in the population are displayed in Table 1, and 
include genes associated with functions such as antibiotic 
resistance, quorum sensing, mucoidy, iron acquisition, amino 
acid metabolism, chemotaxis, cell wall/LPS/capsule synthesis 
and central metabolism (Table 1). The porin protein- encoding 
gene, oprD, had independently acquired nonsense muta-
tions more than any other gene in the population, acquiring 
nonsense mutations a minimum of 32 times and carried by 
51/124 genomes. A further six genomes contained larger 
deletions ranging from 141 to 647 bp (10.63–48.79 %) within 
the 1326 bp oprD gene, bringing the total number of UK LES 
genomes with strong genetic evidence of loss of function in 
OprD to 57. MexA and MexB multidrug efflux pump proteins 
were both inferred to be adaptive by loss of function (Table 1) 
and are both encoded by the mexAB- oprM operon. Taken 
together, the genes encoding the MexAB- OprM efflux pump 
independently acquired loss- of- function mutations at least 
26 times, in 50 isolates.
Deficiency in DNA mismatch repair as a result of disrup-
tion to genes mutS, mutL, mutM and uvrD can result in the 
hypermutable phenotype, another adaptation that has been 
observed previously amongst P. aeruginosa CF isolates [66]. 
In the LES dataset, 10/124 genomes investigated were identi-
fied as probable hypermutators due to DNA mismatch repair 
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deficiency. There was also evidence of cross- infection of 
hypermutable lineages. Isolates LiP10a/b and LiP13, from two 
different CF patients attending the same centre, are adjacent 
on the core SNP tree (Fig. 2) and carry a 4 bp deletion in 
mutM at the same position. In addition, isolates PHELES3 
and PHELES6, also from to different patients attending the 
same CF centre, are adjacent on the core SNP tree (Fig. 2) and 
share 57 bp of a 58 bp deletion in mutM.
DISCUSSION
Phylogenetic analysis of the LES
Previously, a limited number of LES genomes were available 
for comparative genomics [8, 29] and studies focused on the 
within- host diversity and adaptation of LES lineages during 
chronic lung infections [30, 65]. As well as greatly increasing 
the sample size for comparative genomics, the panel of LES 
isolates for this study significantly extends the geographical 
diversity of samples, and the diversity of associated patholo-
gies. Using this extended dataset, we show that the LES forms a 
distinct clonal lineage, and that UK and Canadian LES isolates 
form distinct clades (Figs 1 and 2). There were two excep-
tions in the 145 isolate dataset, both of which were sourced in 
the UK but clustered with the isolates from Canada. For one 
(LiP6), further clinical data linked the patient with Canada. 
We were unable to find sufficient information to explain 
the location of the second (PHELES19). Nevertheless, the 
divergence between the isolates from Canada and UK, with 
the earliest known LES isolate (LESB58) lying between the 
groups, suggests that the LES may have established itself in 
Table 1. LESB58 genes in the UK LES population inferred to have independently acquired nonsense mutations four or more times
No. of independent 
acquisitions
Gene name No. of genomes Gene description
32 oprD 51 Imipenem outer- membrane porin
18 lasR 26 Transcriptional regulator of quorum sensing
21 mexB 43 Multidrug efflux pump transporter, part of the mexAB- oprM operon
20 PLES_59241 32 Hypothetical membrane protein
13 mucA 29 Anti- sigma factor for alginate biosynthesis
10 glpT 15 Sn- glycerol-3- phosphate transporter
9 mltD 55 Murein transglycosylase D precursor
8 pncA 10 Nicotinamidase
7 PLES_34011 13 TonB- dependent receptor
6 PLES_48481 16 Hypothetical protein
6 pmrB 6 Two- component regulator system
5 PLES_46251 12 Putative glycosyl transferase
5 opmQ 7 Putative outer- membrane protein precursor
5 PLES_16021 5 Transcriptional regulator (marR orthologue, involved in repression of MDR mar operon)
5 mpl 11 UDP- N- acetylmuramate:L- alanyl- gamma- d- glutamyl- meso- diaminopimelate ligase
5 chpA 5 Chemosensory system component
5 PLES_51581 5 Putative S- adenosylmethionine decaboxylase proenzyme
5 mdoH 13 Glucosyltransferase involved in biofilm formation
5 ampD 111 N- acetyl- anhydromuranmyl- l- alanine amidase
4 PLES_46401 101 Hypothetical protein with filamentous haemagglutinin outer- membrane domain)
4 PLES_03151 9 Transcriptional regulator
4 PLES_47771 8 Two- component sensor
4 pchE 7 Dihydroaeruginoic acid synthase
4 mexA 7 Multidrug efflux pump transporter, part of the mexAB- oprM operon
4 PLES_07571 5 Putative oxidoreductase
4 PLES_29121 7 Putative ATP- binding/permease fusion ABC transporter involved in sulphate metabolism
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both countries some decades ago and then undergone within- 
country spread.
There were seven genes with mutations leading to amino acid 
substitutions in all of the clade II genomes (UK) but none of 
the clade I genomes (Canada), and a further gene PLES_53461 
with a mutation upstream in all clade II genomes. These 
included genes encoding the regulatory protein NosR, a 
predicted two- component regulatory protein (PLES_28161), 
transport proteins (PLES_13941 and PLES_44581), a ring 
cleavage dioxygenase (PLES_44361), a putative hydroxylase 
(PLES_48951) and DNA gyrase (gyrB). loss- of- function 
mutations in genes encoding two other regulatory proteins 
(FleR and GltR) were also found in the majority of clade 
II isolates. It is possible that some of these mutations have 
contributed to the adaptations allowing this strain to be 
transmissible. However, if this is the case, then the spread of 
the clade I isolates in Canada must have been facilitated by 
other adaptations.
There was evidence for clustering by geography within the 
UK. Again, there were exceptions, some of which could be 
explained by follow- up epidemiological investigations. Our 
sample was dominated by isolates from the North West 
(Liverpool) region. Notably, not all isolates from this region 
clustered together. Rather, there were several separate clusters, 
some indicating closer relationships with isolates from other 
regions, consistent with some sub- lineages seeding geograph-
ical spread, followed by divergence. It is not uncommon for 
CF patients to move from one area to another within the UK, 
and we cannot construct an entirely accurate natural history 
of the strain based on the limited clinical and epidemiological 
data available.
Variations in the accessory genome content
The genome of the earliest isolate of the LES (LESB58) 
contains large GIs and prophages, some of which harbour 
genes shown to contribute to competitiveness in an animal 
model of chronic infections [26, 27, 67]. It has also been shown 
that LES prophages are active as free phage in the sputum of 
CF patients [28]. However, it is clear that LES isolates can 
vary in their complement of GIs and prophages, and also that 
some GIs and prophages were more often absent or divergent 
than others. For example, carriage of LES prophage 5 was 
restricted to sub- sets of isolates from the same CF region 
(Liverpool). This might support the notion that the strain 
first evolved in Liverpool, given that prophage 5 was present 
in the earliest known isolate, and that loss of the unstable 
prophage occurred before spread, but we cannot rule out 
acquisition restricted to some isolates. Interestingly, absence 
of the most variable GI (GI-5) was also mostly associated 
with sub- sets of isolates from this same region. In contrast, 
absence of GI-2 or GI-3 was rare, as was complete absence 
of the other LES prophages, implying that they contribute 
to the success of their host during chronic CF infections. In 
particular, genes associated with prophages 3 and 4 and GI 
GI-3 featured prominently amongst those genes associated 
with the LES in comparison to other P. aeruginosa strains, 
including in prophage 3, genes putatively encoding a HicA/
HicB toxin–antitoxin system, implicated in the stringent 
response and persistence [68]. Previous studies support the 
notion that LES prophages contribute to the establishment of 
chronic lung infections [27], and our data support the idea 
that these accessory regions are making an important contri-
bution to the success of the LES. It is worth noting that the 
isolate PHELES19, from an unusual source (blood), was also 
unusual in that it lacked GI-3 and most of the LES prophages. 
Generally, isolates that clustered closely according to core 
genome SNP phylogeny tended to share the same comple-
ment of GIs and prophages, suggesting that instability has 
occurred during transmission and spread of the LES lineage, 
but not so rapidly that closely related isolates do not broadly 
share the same accessory genome content.
LES adaptations
We identified a number of loss- of- function mutations previ-
ously associated with the LES. For example, fleR mutations, 
associated with loss of motility, a characteristic of many 
P. aeruginosa isolates from CF infections [69], and a defining 
characteristic of the LES [29], were identified in all but one of 
the UK isolates but not in the isolates from Canada.
Although adaptations to the CF lung occurring by mutation 
have been widely reported [70], we also found evidence for 
adaptation via the loss of large genomic regions. We identi-
fied a large region, including genes for extracellular poly-
saccharide (Psl), a siderophore (pyoverdine) and a type VI 
secretion system, that was deleted from the genomes of 15 of 
the LES isolates (Fig. S4). The boundaries of these deletions 
differed between isolates, and additional, different deletions 
were present in some isolates, indicating the occurrence of 
independent deletion events and a tendency towards genome 
reduction during chronic infection. Biofilm formation is 
considered to be an important strategy for P. aeruginosa during 
chronic lung infections, and the bacterium can produce three 
different exopolysaccharides that contribute to this process, 
namely Psl, Pel and alginate [71]. Alginate has been strongly 
implicated in P. aeruginosa CF infections because of the obser-
vation that many isolates express a mucoid phenotype due to 
over- production of alginate because of mutations, especially 
in mucA [72, 73]. Although the contributions of Pel and Psl 
during CF infections are less well understood, it has been 
shown that a LES isolate favours expression of pel genes over 
psl genes in a murine model of chronic lung infection [74]. 
Mutations in the pyoverdine biosynthesis genes are a common 
adaptation in CF, and P. aeruginosa adapts to favour iron 
acquisition from haemoglobin rather than via siderophores 
[75, 76]. Hence the loss of genes encoding Psl or pyoverdine 
would be consistent with previous analysis of P. aeruginosa 
adaptions. Since the type VI secretion system is a weapon 
employed by bacteria to attack competitors, loss of this system 
in the highly competitive multi- species environment of the 
CF lung is harder to understand. However, it may be that 
in a biofilm lifestyle within the structurally heterogeneous 
environment of the CF lung, over time P. aeruginosa can 
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establish itself in niches where there is no requirement for 
these weapons.
We also observed many independent mutations in genes 
previously implicated in adaptive responses during 
P. aeruginosa chronic lung infections [70]. Some of these were 
loss- of- function mutations. Mutations leading to mucoidy 
(mucA) or impairment of quorum sensing (lasR) are amongst 
the most common reported adaptations in P. aeruginosa 
chronic lung infections [70, 77]. Some of these were loss- of- 
function mutations. We also observed common antimicrobial 
resistance- associated mutations, including pmrB mutations, 
which have been associated with adaptation to the lung in a 
murine chronic infection model [78].
Inactivation of oprD in P. aeruginosa results in carbapen-
emase resistance, a growing problem with P. aeruginosa 
[79]. Decreased expression of oprD in LES400 and LES431 
compared with PAO1 has been shown to correlate with an 
increase in minimum inhibitory concentrations (MICs) for 
meropenem [80]. Disruptive mutations in the PAO1 mltD 
homologue (PA1812) have been associated with increased 
beta- lactam antibiotic MICs [81] and in P. aeruginosa PA14 
disruptive mutations in the glpT gene result in fosfomycin 
resistance [82]. Disruption of mpl homologues in P. aerugi-
nosa have additionally been associated with piperacillin and 
ceftazidime resistance due to an accumulation of immature 
cell wall components and up- regulation of AmpC expression 
[83].
The loss of the MexAB- OprM efflux pump, due to severe 
mutations in any of the genes in the mexAB- oprM operon, 
has also been observed in non- CF bronchiectasis chronic lung 
infections [77]. This is harder to explain in terms of an adapta-
tion leading to antibiotic resistance. The efflux pump has also 
been implicated in virulence, and it may be this alternative 
role that is more important in the CF lung adaptation [84].
Although we have identified mutations via analysis of the 
genomic data, we do not here present phenotypic data to 
demonstrate linkage between the genetic variations and 
specific phenotypic adaptations.
CONCLUSIONS
Most CF patients acquire their P. aeruginosa from environ-
mental sources; transmissible (epidemic) strains capable of 
spreading by transmission between patients are therefore 
unusual. Here we have demonstrated that isolates identified 
as the LES belong to a distinct lineage when compared to 
other P. aeruginosa strains and separate by core genome SNP 
phylogeny on the basis of country of isolation (UK or Canada). 
In addition to transmissibility, in both nations, the LES has 
been associated with greater patient morbidity [12, 85]. In 
CF, P. aeruginosa causes long- term chronic infections, and 
during the course of such infections P. aeruginosa populations 
not only acquire adaptive mutations, but also evolve to be 
heterogeneous [30, 70]. For our isolate collection, we cannot 
know how far down this adaptive process the P. aeruginosa 
population sampled has travelled at the point the isolate was 
obtained. Hence, attempts to reconstruct a global LES evolu-
tionary history based upon substitution rates would not yield 
meaningful insights. However, we observed that the oldest 
known isolates (LESB58, from 1988) falls between the two 
major clades (associated with the UK or Canada), and that 
there are variations between the clades in terms of signature 
mutations and the carriage of accessory genes. These findings 
suggest (a) that the LES lineage established itself separately in 
the UK and Canada some considerable time ago and (b) that 
the special characteristics of the lineage in terms of greater 
competitiveness, the ability to spread and associations with 
increased morbidity, cannot easily be assigned to shared 
mutations or accessory gene content.
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